Can-Fite Biopharma (CANF) Q3 2024 Earnings

Aug 29Confirmed
Q4 2022
Q1 2023
Q2 2024
Q3 2024
-0.19
-0.13
-0.06
0

Details

Expected EPS
-0.000366
Actual EPS
-0.001099
Surprise EPS
-0
Surprise Percent
-200.27%

Description

⁨Can-Fite Biopharma⁩ (⁦CANF⁩) has reported earnings of ⁦-0.001099⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts